Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Double nerve block may ease hip surgery pain

NCT ID NCT07263932

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two nerve block methods for pain after total hip replacement. One group gets a standard front-hip block, the other gets that plus a back-hip block. Researchers will measure pain scores, recovery quality, and how quickly patients can move after surgery. The goal is to see if the combo block provides better pain relief and faster recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bupivacaine
What this could lead to
If it works, this could lead to better pain control and faster recovery after hip replacement surgery.
What could go wrong
This is a small, early-stage study comparing two nerve block techniques. The results may not apply to all patients, and there is a risk of block-related complications like nerve injury or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

127 people

The number who actually took part.

Started

Dec 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients aged 18 years and older, classified as ASA physical status I-II, scheduled for elective total hip arthroplasty under spinal anesthesia at Ankara Bilkent City Hospital. A total of 132 patients who meet the inclusion criteria and provide written informed consent will be enrolled in this single-center, prospective, randomized controlled trial.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients scheduled for elective total hip arthroplasty (THA) under spinal anesthesia * ASA physical status I-II * Age ≥18 years * Body Mass Index (BMI) between 18-35 kg/m² * Patients who provide written informed consent Exclusion Criteria: * Age \<18 years * ASA physical status ≥III * Known allergy or contraindication to study medications (local anesthetics, opioids, etc.) * Severe cardiac, renal, hepatic, or pulmonary failure * Revision total hip arthroplasty * Coagulopathy or anticoagulant use * Local infection or neuropathic findings at the injection site * Chronic inflammatory diseases or chronic corticosteroid use * Diagnosed neuropsychiatric disorders * Pregnancy or lactation * Inability or unwillingness to read, understand, or sign the informed consent form * Obesity (BMI \>35 kg/m²) * Failed spinal anesthesia or conversion to general anesthesia * Active malignancy or patients receiving radiotherapy/chemotherapy * Active systemic infection or ongoing antibiotic therapy (except prophylaxis) * Contraindication to regional anesthesia techniques * Chronic opioid or analgesic use for pain disorders * History of intracranial mass, increased intracranial pressure, epilepsy, cerebrovascular accident, neuromuscular disease, or motor/sensory deficits

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip arthroplasty, total are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara Bilkent City Hospital Departmant of Anesthesiology and Reanimation, Ankara,Çankaya

    Ankara, Çankaya, 06800, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.